BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1020119)

  • 1. Plasma 5alpha androstanediol: an androgen marker of hirsuitism in women.
    Meikle AW; Stringham JD; Dolman LI; Lagerquist LG; Tyler FH
    Trans Assoc Am Physicians; 1976; 89():133-45. PubMed ID: 1020119
    [No Abstract]   [Full Text] [Related]  

  • 2. The determination of 5alpha-androstane-3alpha, 17beta-diol in human plasma by radioimmunoassay.
    Laband P; Tresguerres JA; Lisboa BP; Volkwein U; Tamm J
    Acta Endocrinol (Copenh); 1978 Aug; 88(4):778-86. PubMed ID: 581118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of serum testosterone and its reduction products.
    Strickland AL; Apland M
    South Med J; 1977 Apr; 70(4):426-8. PubMed ID: 191933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous radioimmunoassay of 5alpha-androstane-3alpha, 17beta-diol and 5alpha-androstane-3beta, 17beta-diol unconjugated and conjugated in human serum.
    Habrioux G; Desfosses B; Condom R; Faure B; Jayle M
    Steroids; 1978; 32(1):61-71. PubMed ID: 705818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous radioimmunoassay of tesosterone, dihydrotestosterone, 5 alpha-androstane-3alpha, 17beta-diol and 5alpha-androstane-3beta, 17beta-diol in the plasms of adult male rats.
    Corpéchot C; Eychenne B; Robel P
    Steroids; 1977 Apr; 29(4):503-16. PubMed ID: 867448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen administration on androgen production and plasma luteinizing hormone in hirsute women.
    Kirschner MA; Bardin CW; Hembree WC; Ross GT
    J Clin Endocrinol Metab; 1970 Jun; 30(6):727-32. PubMed ID: 5444560
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of plasma 5 alpha-androstane-3 alpha, 17 beta-diol in the hirsute woman. A critical study of the biological diagnosis of hyperandrogenism].
    Heim J; Massart C
    Nouv Presse Med; 1982 Nov; 11(47):3495-9. PubMed ID: 6218480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R; Hawks D; Lobo R
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 5alpha-androstane-3alpha, 17beta-diol, androsterone and testosterone concentrations in the immature male rat: influence of time of day.
    Moger WH; Murphy PR
    J Endocrinol; 1977 Oct; 75(1):177-8. PubMed ID: 925585
    [No Abstract]   [Full Text] [Related]  

  • 12. Androstanediol glucuronide, a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
    Vermeulen A
    Acta Endocrinol (Copenh); 1991 Sep; 125(3):335. PubMed ID: 1950345
    [No Abstract]   [Full Text] [Related]  

  • 13. Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
    Carmina E; Stanczyk FZ; Gentzchein E; Lobo RA
    Gynecol Endocrinol; 1995 Sep; 9(3):215-20. PubMed ID: 8540291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of androstanediol in plasma in a radioimmunoassay using celite column chromatography.
    Barberia J; Pages L; Horton R
    Fertil Steril; 1976 Sep; 27(9):1101-4. PubMed ID: 964402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical usefulness of 3 alpha-androstanediol glucuronide in premenopausal women with hirsutism.
    Moses RG; Theile H; Colagiuri S
    Aust N Z J Obstet Gynaecol; 1994 May; 34(2):208-10. PubMed ID: 7980317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of unconjugated 5alpha-androstan-3beta,17beta-diol in human peripheral plasma as measured by radioimmunoassay.
    Hopskinson CR; Park BK; Johnson MW; Sturm G; Steinbach K; Hirschhäuser C
    J Steroid Biochem; 1977 Dec; 8(12):1253-7. PubMed ID: 592786
    [No Abstract]   [Full Text] [Related]  

  • 18. A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3alpha-androstanediol (5alpha-androstane-3alpha,17beta-diol) in plasma.
    Reddy DS; Venkatarangan L; Chien B; Ramu K
    Steroids; 2005 Dec; 70(13):879-85. PubMed ID: 16040068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical value of 3 alpha-androstanediol-glucuronide in hirsute women].
    Joura EA; Sator MO; Geusau A; Zeisler H; Söregi G; Huber JC
    Wien Klin Wochenschr; 1997 Dec; 109(23):919-21. PubMed ID: 9487606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary androstanediol and testosterone in adults.
    Doberne Y; New MI
    J Clin Endocrinol Metab; 1976 Jan; 42(1):152-4. PubMed ID: 1249183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.